White Paper
Strategic Implications Of Packaging Choice In The Generic Sector
The Honeywell Generics Forum, held in 2009 in Brussels, brought together over 20 senior management attendees from 15 companies in 11 countries for a topical debate on the current issues facing the industry as well as to examine new packaging strategies.
The generics sector has been experiencing an unprecedented period of growth and generic firms are set to further capitalise on the opportunities offered by patent expiry on an estimated $150B worth of revenues by 2015.
Generics contribute to the long-term affordability of healthcare systems. Drivers such as aging populations, increasing medical consumption, cost containment and restrictions in government healthcare budgets have all brought about increasing focus on the cost savings offered by the generic drug industry.
The content you requested is only available to registered users of Pharmaceutical Online. By registering now, you'll get exclusive access to this piece of content and thousands of addtional articles and product reviews across our entire network of sites.
